New drug combinations could improve therapies for breast cancer, other aggressive cancers
OHSU study finds drug combinations slow progression of the cancer and lead to cancer regression.
Research
More Research Stories
- Latest Stories
OHSU names new director of Oregon National Primate Research Center
March 17, 2023
Skip Bohm, a veterinarian, will lead center beginning in August.
OHSU investigators awarded funding to extend leading-edge research
February 03, 2023
Awards will establish a Latino health research center, innovate durable biomedical devices and help fight cancer.
OHSU physician-scientist pioneers research to better understand maternal sleep apnea
February 02, 2023
Study will evaluate the impact of sleep apnea on fetal brain development, postnatal health outcomes.
OHSU neuroscientist: Grammy nominees are a brainy bunch
January 30, 2023
Practicing — or even listening to — music directly benefits brain health, function.
OHSU part of clinical trial aiming to prevent Alzheimer’s before symptoms start
January 26, 2023
Participant says she’s committed to preventing Alzheimer’s in her daughters’ generation.
OHSU researchers find immune response to COVID-19 strengthens over time
January 25, 2023
Study suggests people who have had COVID-19 benefit from vaccination, even if they’ve delayed it.
Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer
January 17, 2023
Treatment with sodium thiosulfate will improve health outcomes and quality of life for pediatric cancer patients.
Increasing cancer awareness, screening in underserved communities
January 12, 2023
OHSU funds projects to provide culturally relevant resources, education, workshops for people across Oregon.
Nanotechnology may improve gene therapy for blindness
January 11, 2023
New OHSU, OSU research uses lipid nanoparticles to target light-sensitive cells in the eye.
Artificial intelligence, diabetes experts combine forces for blood sugar management study
January 10, 2023
Smartphone app being improved to better help patients control their type 1 diabetes.